The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The serotonin syndrome is a medication-induced condition resulting from serotonergic hyperactivity, usually involving antidepressant medications. As the number of patients experiencing medically-treated major depressive disorder increases, so does the population at risk for experiencing serotonin syndrome. Excessive synaptic stimulation of 5-HT2A receptors results in autonomic and neuromuscular aberrations with potentially life-threatening consequences. In this review, we will outline the molecular basis of the disease and describe how pharmacologic agents that are in common clinical use can interfere with normal serotonergic pathways to result in a potentially fatal outcome. Given that serotonin syndrome can imitate other clinical conditions, an understanding of the molecular context of this condition is essential for its detection and in order to prevent rapid clinical deterioration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Mojtabai, R., & Olfson, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08443 · Cited by 247
A review of the management of antidepressant discontinuation symptoms
Wilson, E., & Lader, M. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315612334 · Cited by 103
Cited by
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., Kaye, A. D., Viswanath, O., Urits, I., Boyer, A. G., et al. (2021) · Neurology International · doi:10.3390/neurolint13030038 · Cited by 440
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010181 · Cited by 236
“Serotonin syndrome can trigger other clinical conditions; therefore, in order to detect the syndrome and prevent rapid clinical deterioration, it is important to better understand the molecular context of this condition [131].”
Ferraz-Bannitz, R., Ozturk, B., Cummings, C., Efthymiou, V., Casanova Querol, P., Poulos, L., Wang, H., Navarrete, V., Saeed, H., Mulla, C. M., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180157 · Cited by 12
“…symptoms experienced by PBH patients in the postprandial state show some similarities to those in individuals who have serotonin syndrome, a condition induced by SSRIs and other serotoninergic medications (54) and manifested by confusion, sweating, tremors, and, in more severe cases, seizures (55).”
Spanakis, M., Bakaros, E., Papadopoulou, S.-N., Fournaraki, A., & Symvoulakis, E. K. (2025) · Pharmacoepidemiology · doi:10.3390/pharma4040022 · Cited by 6
“…characteristic triad of symptoms often diagnosed using the Hunter serotonin toxicity criteria: neuromuscular excitation (e.g., tremor, clonus, hyperreflexia), autonomic instability (e.g., hypertension, tachycardia, hyperthermia), and altered mental status (e.g., agitation, confusion) [38,39,46,50].”
Metadata
- Authors
- Francescangeli, J., Karamchandani, K., Powell, M., & Bonavia, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-05-09
- Volume
- 20
- Issue
- 9
- Pages
- 2288
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2944814016
- Cited by
- 159
- References
- 4
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.